Cost Effectiveness of Immunoprophylaxis in the Prevention of Recurrent Infectious Rhinitis in Adults
- 1 January 1998
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 14 (3) , 313-322
- https://doi.org/10.2165/00019053-199814030-00007
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effectiveness of ribosomal fractions of Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and the membrane fraction of Kp (Ribomunyl) in the prevention of clinical recurrences of infectious rhinitis. Results of a multicenter double-blind placebo-controlled study.1997
- Current estimates from the National Health Interview Survey, 1993.1994
- Economic Evaluation of Immunoprophylaxis in Children with Recurrent Ear, Nose and Throat InfectionsPharmacoEconomics, 1994
- Antibody-producing cells in peripheral blood and tonsils after oral treatment of children with bacterial ribosomesInternational Journal of Immunopharmacology, 1994
- Economic Analysis in Randomized Control TrialsMedical Care, 1992
- Peripheral blood specific antibody-forming cells after oral stimulation with a ribosomal vaccine.1992
- Economic Analysis Alongside Clinical Trials: Revisiting the Methodological IssuesInternational Journal of Technology Assessment in Health Care, 1991
- Increase in specific antibody-forming cells in human tonsils after oral stimulation with D-53 a ribosomal vaccineInternational Journal of Immunopharmacology, 1990